Centre Hospitalier Universitaire de Nîmes - Institut de Cancérologie du Gard - Hôpital Universitaire

Nîmes, GARD 30029

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Studies at this site

• A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1). — Running, not enrolling